en

PRODUCT DETAIL

Tevimbra 100 mg koncentrát na infúzny roztok

Code 4387E
MA number EU/1/23/1758/002
Product Form: con inf 2(2x1)x10 ml/100 mg (liek.inj.skl. - viacnás.bal.)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
Therapeutic Class: 44 - CYTOSTATICA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01 ANTINEOPLASTIC AGENTS
L01F MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES
L01FF PD-1/PDL-1 (Programmed cell death protein 1/death ligand 1) inhibitors
L01FF09 Tislelizumab
Shelf life: 36
Container: glass vial
Route of admin.: Intravenous use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 8(3) application - new active substance
MA issued: 15.09.2023
Validity: 15.09.2028
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 21.09.2023
eu-flag.png sk-flag.png